209 related articles for article (PubMed ID: 15385114)
1. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
[TBL] [Abstract][Full Text] [Related]
2. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M
Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia.
Orbo A; Nilsen MN; Arnes MS; Pettersen I; Larsen K
Int J Gynecol Pathol; 2003 Apr; 22(2):141-8. PubMed ID: 12649668
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis.
Martini M; Ciccarone M; Garganese G; Maggiore C; Evangelista A; Rahimi S; Zannoni G; Vittori G; Larocca LM
Int J Cancer; 2002 Dec; 102(4):398-406. PubMed ID: 12402310
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma.
Baldinu P; Cossu A; Manca A; Satta MP; Pisano M; Casula M; Dessole S; Pintus A; Tanda F; Palmieri G
Cancer; 2002 Jun; 94(12):3157-68. PubMed ID: 12115348
[TBL] [Abstract][Full Text] [Related]
8. The molecular biology of endometrial tumorigenesis: does it have a message?
Ellenson LH
Int J Gynecol Pathol; 2000 Oct; 19(4):310-3. PubMed ID: 11109158
[No Abstract] [Full Text] [Related]
9. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA
Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567
[TBL] [Abstract][Full Text] [Related]
10. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
[TBL] [Abstract][Full Text] [Related]
11. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas.
Minaguchi T; Yoshikawa H; Oda K; Ishino T; Yasugi T; Onda T; Nakagawa S; Matsumoto K; Kawana K; Taketani Y
Clin Cancer Res; 2001 Sep; 7(9):2636-42. PubMed ID: 11555573
[TBL] [Abstract][Full Text] [Related]
12. [Genetic diagnosis of endometrial cancer].
Kanaya T; Kyo S; Maida Y; Inoue M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():295-8. PubMed ID: 15535254
[No Abstract] [Full Text] [Related]
13. The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.
Konopka B; Janiec-Jankowska A; Paszko Z; Goluda M
J Cancer Res Clin Oncol; 2004 Feb; 130(2):114-21. PubMed ID: 14663583
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification of latent precancers in histologically normal endometrium.
Mutter GL; Ince TA; Baak JP; Kust GA; Zhou XP; Eng C
Cancer Res; 2001 Jun; 61(11):4311-4. PubMed ID: 11389050
[TBL] [Abstract][Full Text] [Related]
15. Causes and consequences of microsatellite instability in endometrial carcinoma.
Gurin CC; Federici MG; Kang L; Boyd J
Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063
[TBL] [Abstract][Full Text] [Related]
16. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.
Wang H; Douglas W; Lia M; Edelmann W; Kucherlapati R; Podsypanina K; Parsons R; Ellenson LH
Am J Pathol; 2002 Apr; 160(4):1481-6. PubMed ID: 11943731
[TBL] [Abstract][Full Text] [Related]
17. [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].
Xu B; Yao Q; Dai SZ
Ai Zheng; 2004 Jan; 23(1):69-73. PubMed ID: 14720379
[TBL] [Abstract][Full Text] [Related]
18. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.
Mutter GL; Lin MC; Fitzgerald JT; Kum JB; Baak JP; Lees JA; Weng LP; Eng C
J Natl Cancer Inst; 2000 Jun; 92(11):924-30. PubMed ID: 10841828
[TBL] [Abstract][Full Text] [Related]
19. [Genetic abnormalities in endometrial cancer].
Takeshima N; Hirai Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():254-8. PubMed ID: 15535246
[No Abstract] [Full Text] [Related]
20. PTEN mutations and evolving concepts in endometrial neoplasia.
Latta E; Chapman WB
Curr Opin Obstet Gynecol; 2002 Feb; 14(1):59-65. PubMed ID: 11801878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
